,Herzing NU 636 Final Exam | Advanced
Pharmacology (2026) Q&A
1. Which of the following statements best describes the primary focus of
pharmacokinetics?
A) The study of how drugs produce their therapeutic and adverse effects in the body
B) The study of how the body absorbs, distributes, metabolizes, and excretes drugs
C) The study of how genetic variations affect individual responses to medications
D) The study of the therapeutic uses and clinical applications of drug therapy
Correct Answer: B) The study of how the body absorbs, distributes, metabolizes, and
excretes drugs
Rationale: Pharmacokinetics describes what the body does to the drug and includes
absorption, distribution, metabolism, and excretion (ADME). Pharmacodynamics is
the study of how drugs affect the body, pharmacogenomics examines genetic
influences on drug response, and pharmacotherapeutics focuses on therapeutic uses.
2. What is the primary difference between bioavailability and bioequivalence?
A) Bioavailability measures the fraction of a drug reaching systemic circulation, while
bioequivalence compares the similarity between two drug formulations in
bioavailability and effects
B) Bioavailability assesses the rate of drug absorption, while bioequivalence measures
the extent of drug distribution in tissues
C) Bioavailability refers to the drug's concentration in plasma, while bioequivalence
determines the interchangeability of two formulations
D) Bioavailability evaluates the drug's therapeutic efficacy, while bioequivalence
compares the safety profiles of two formulations
,Correct Answer: A) Bioavailability measures the fraction of a drug reaching systemic
circulation, while bioequivalence compares the similarity between two drug
formulations in bioavailability and effects
Rationale: Bioavailability is the fraction of an administered dose that reaches
systemic circulation. Bioequivalence refers to the similarity between two formulations
in terms of bioavailability and pharmacological effects. Factors such as first-pass
metabolism affect bioavailability.
3. A drug with a narrow therapeutic index requires careful monitoring because:
A) The drug has a wide margin of safety between therapeutic and toxic doses
B) The drug has a small difference between therapeutic and toxic doses
C) The drug is only effective in a narrow patient population
D) The drug requires a narrow route of administration
Correct Answer: B) The drug has a small difference between therapeutic and toxic
doses
Rationale: A narrow therapeutic index means there is a small margin between the
therapeutic dose and the toxic dose. Drugs like digoxin, warfarin, and phenytoin
require close monitoring of serum levels to avoid toxicity while maintaining efficacy.
4. A patient is prescribed a medication that is a weak acid. How will the medication's
absorption be affected if the patient takes an antacid that raises gastric pH?
A) Absorption will increase because weak acids are better absorbed in an alkaline
environment
B) Absorption will decrease because weak acids are better absorbed in an acidic
environment
C) Absorption will remain unchanged because antacids do not affect drug absorption
D) Absorption will increase because antacids increase gastric motility
, Correct Answer: B) Absorption will decrease because weak acids are better
absorbed in an acidic environment
Rationale: Weak acids are better absorbed in an acidic environment where they are
non-ionized and more lipid-soluble. Raising gastric pH with an antacid increases
ionization, which reduces the drug's ability to cross cell membranes, leading to
decreased absorption.
5. A patient is receiving a medication that is 90% protein bound. What is the clinical
significance of this high protein binding?
A) The medication will have a rapid onset of action
B) The medication will have a long duration of action
C) Only a small fraction of the drug is free and pharmacologically active
D) The medication will be rapidly excreted by the kidneys
Correct Answer: C) Only a small fraction of the drug is free and pharmacologically
active
Rationale: Only the unbound (free) fraction of a drug is pharmacologically active.
High protein binding means a small fraction is free, but changes in protein binding
(e.g., due to hypoalbuminemia or displacement by another drug) can significantly
alter free drug levels and effect.
6. A medication that undergoes significant first-pass metabolism is administered.
Which route would most effectively bypass this effect?
A) Oral
B) Sublingual
C) Intravenous
Pharmacology (2026) Q&A
1. Which of the following statements best describes the primary focus of
pharmacokinetics?
A) The study of how drugs produce their therapeutic and adverse effects in the body
B) The study of how the body absorbs, distributes, metabolizes, and excretes drugs
C) The study of how genetic variations affect individual responses to medications
D) The study of the therapeutic uses and clinical applications of drug therapy
Correct Answer: B) The study of how the body absorbs, distributes, metabolizes, and
excretes drugs
Rationale: Pharmacokinetics describes what the body does to the drug and includes
absorption, distribution, metabolism, and excretion (ADME). Pharmacodynamics is
the study of how drugs affect the body, pharmacogenomics examines genetic
influences on drug response, and pharmacotherapeutics focuses on therapeutic uses.
2. What is the primary difference between bioavailability and bioequivalence?
A) Bioavailability measures the fraction of a drug reaching systemic circulation, while
bioequivalence compares the similarity between two drug formulations in
bioavailability and effects
B) Bioavailability assesses the rate of drug absorption, while bioequivalence measures
the extent of drug distribution in tissues
C) Bioavailability refers to the drug's concentration in plasma, while bioequivalence
determines the interchangeability of two formulations
D) Bioavailability evaluates the drug's therapeutic efficacy, while bioequivalence
compares the safety profiles of two formulations
,Correct Answer: A) Bioavailability measures the fraction of a drug reaching systemic
circulation, while bioequivalence compares the similarity between two drug
formulations in bioavailability and effects
Rationale: Bioavailability is the fraction of an administered dose that reaches
systemic circulation. Bioequivalence refers to the similarity between two formulations
in terms of bioavailability and pharmacological effects. Factors such as first-pass
metabolism affect bioavailability.
3. A drug with a narrow therapeutic index requires careful monitoring because:
A) The drug has a wide margin of safety between therapeutic and toxic doses
B) The drug has a small difference between therapeutic and toxic doses
C) The drug is only effective in a narrow patient population
D) The drug requires a narrow route of administration
Correct Answer: B) The drug has a small difference between therapeutic and toxic
doses
Rationale: A narrow therapeutic index means there is a small margin between the
therapeutic dose and the toxic dose. Drugs like digoxin, warfarin, and phenytoin
require close monitoring of serum levels to avoid toxicity while maintaining efficacy.
4. A patient is prescribed a medication that is a weak acid. How will the medication's
absorption be affected if the patient takes an antacid that raises gastric pH?
A) Absorption will increase because weak acids are better absorbed in an alkaline
environment
B) Absorption will decrease because weak acids are better absorbed in an acidic
environment
C) Absorption will remain unchanged because antacids do not affect drug absorption
D) Absorption will increase because antacids increase gastric motility
, Correct Answer: B) Absorption will decrease because weak acids are better
absorbed in an acidic environment
Rationale: Weak acids are better absorbed in an acidic environment where they are
non-ionized and more lipid-soluble. Raising gastric pH with an antacid increases
ionization, which reduces the drug's ability to cross cell membranes, leading to
decreased absorption.
5. A patient is receiving a medication that is 90% protein bound. What is the clinical
significance of this high protein binding?
A) The medication will have a rapid onset of action
B) The medication will have a long duration of action
C) Only a small fraction of the drug is free and pharmacologically active
D) The medication will be rapidly excreted by the kidneys
Correct Answer: C) Only a small fraction of the drug is free and pharmacologically
active
Rationale: Only the unbound (free) fraction of a drug is pharmacologically active.
High protein binding means a small fraction is free, but changes in protein binding
(e.g., due to hypoalbuminemia or displacement by another drug) can significantly
alter free drug levels and effect.
6. A medication that undergoes significant first-pass metabolism is administered.
Which route would most effectively bypass this effect?
A) Oral
B) Sublingual
C) Intravenous
